	US 12,133,902 B2
	Dental composition
Satoshi Jin, Tokyo (JP); Takumasa Kimura, Tokyo (JP); and Kyousuke Hirano, Tokyo (JP)
Assigned to GC Corporation, Shizuoka (JP)
Appl. No. 17/275,322
Filed by GC Corporation, Shizuoka (JP)
PCT Filed Apr. 22, 2019, PCT No. PCT/JP2019/017020 § 371(c)(1), (2) Date Mar. 11, 2021, PCT Pub. No. WO2020/066099, PCT Pub. Date Apr. 2, 2020.
Claims priority of application No. 2018-179878 (JP), filed on Sep. 26, 2018.
Prior Publication US 2022/0047465 A1, Feb. 17, 2022
Int. Cl. A61K 6/887 (2020.01); A61K 6/16 (2020.01); A61K 6/20 (2020.01); A61K 6/30 (2020.01); A61K 6/66 (2020.01); C08L 33/10 (2006.01); C09D 133/06 (2006.01)

CPC A61K 6/887 (2020.01) [A61K 6/16 (2020.01); A61K 6/20 (2020.01); A61K 6/30 (2020.01); A61K 6/66 (2020.01); C08L 33/10 (2013.01); C09D 133/068 (2013.01)]

1 Claim

1. A dental composition comprising:

a (meth)acrylate;

an ultraviolet absorber; and

a fluorescent agent,

wherein the ultraviolet absorber has a maximum absorption wavelength outside a range of greater than 320 nm and less than or equal to 500 nm, and

wherein the ultraviolet absorber is at least one of 2-ethylhexyl 2-cyano-3,3- diphenylacrylate or 2-ethylhexyl 4-(dimethylamino) benzoate.